VEGFC and neoplasm: As noted in a previous section, VEGF-C-induced lymphangiogenesis in the tumor site correlates with metastasis and poor prognosis, VEGF-C also promotes tumor immunosuppression, suggesting that inhibiting lymphangiogenesis may reverse immunosuppression and may be clinically beneficial when combined with immunotherapy.